Previously, HDAC6 inhibition significantly compromised the migration and adhesion of Burkitt's lymphoma cells (45) and reduced VLA4 expression in hematopoietic stem cells and acute myeloid leukemia blast cells (46). The gene discussed is HDAC6; the disease is Burkitt lymphoma.